Patent · US Active

Expression vectors for eukaryotic expression systems

US12421524B2 · kind B2 · utility

0Cited by
3References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2019
Grant dateSep 23, 2025
Priority date
Expiry dateSep 30, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/203
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides expression vectors for expressing recombinant proteins (e.g., biologics) in mammalian cells. Also provided are host cells comprising the expression vectors, methods of producing the recombinant proteins, and methods of propagating the expression vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.